RxDoctor Payments Data

Mahan Ghiassi, MD

Neurological Surgery · Louisville, KYNPI 1285827725

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medical Device Business Services, Inc. at 33.0% of the total. Reporting peaked in 2019 at $7,021 and has fallen 87.8% since, to $856 in 2025.

$11,442in general payments, 2019–2025

Across 199 payments — averaging $57.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$4K
  • Medtronic$3K
  • Stryker$2K
  • Microvention, Inc.$845
  • Johnson & Johnson$492
  • Penumbra, Inc.$246
  • plus $510 from 8 others
$15,555in research payments, 2019–2025

Across 21 payments — averaging $740.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$16K

What the payments were for

  • Consulting fees$3,60031%
  • Travel & lodging$1,23211%
  • Food & beverage$6,59058%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,442 in reported general payments places this provider in the 70th percentile of 99 neurological surgery providers in Kentucky.

See all neurological surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$108,486
Medicare patients
189
Services billed
402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate29$160

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →